Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178362 | SCV000230428 | likely benign | not specified | 2015-05-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000711659 | SCV000513041 | likely benign | not provided | 2020-12-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086801 | SCV000630829 | benign | Walker-Warburg congenital muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000711659 | SCV000842046 | benign | not provided | 2018-01-25 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000178362 | SCV002065976 | likely benign | not specified | 2019-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336437 | SCV002640182 | likely benign | Cardiovascular phenotype | 2019-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000711659 | SCV005330842 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | FKRP: BP4, BP7 |
Prevention |
RCV004537462 | SCV004750408 | likely benign | FKRP-related disorder | 2020-01-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |